Motoaki Sano Selected Research

Motoaki Sano Research Topics

Disease

24	Heart Failure 03/2023 - 04/2003
16	Inflammation (Inflammations) 03/2023 - 04/2011
15	Myocardial Infarction 10/2023 - 08/2008
11	Reperfusion Injury 01/2024 - 08/2008
11	Ischemia 10/2023 - 06/2009
11	Fibrosis (Cirrhosis) 03/2023 - 01/2010
10	Hypoxia (Hypoxemia) 12/2023 - 06/2009
9	Infarction (Infarctions) 01/2024 - 08/2008
9	Type 2 Diabetes Mellitus (MODY) 10/2021 - 10/2010
8	Heart Arrest (Cardiac Arrest) 04/2023 - 10/2012
8	Hypertrophy 01/2018 - 11/2002
7	Cardiovascular Diseases (Cardiovascular Disease) 08/2022 - 11/2009
7	Cardiomegaly (Heart Hypertrophy) 10/2021 - 03/2003
6	Hypertension (High Blood Pressure) 01/2021 - 01/2017
5	Cardiomyopathies (Cardiomyopathy) 12/2022 - 09/2004
5	Pulmonary Hypertension 01/2022 - 08/2012
4	Aortic Dissection 03/2023 - 02/2015
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 10/2010
4	Amyloidosis 06/2022 - 12/2019
4	Neoplasms (Cancer) 01/2021 - 01/2013
4	Hemorrhagic Shock 01/2021 - 01/2017
4	Shock 01/2020 - 01/2016
4	Ventricular Remodeling 06/2017 - 02/2014
3	Chronic Renal Insufficiency 04/2024 - 08/2020
3	Atherosclerosis 04/2024 - 07/2009
3	Coma (Comas) 04/2023 - 10/2017
3	Vascular Remodeling 03/2023 - 01/2017
3	Obesity 01/2022 - 01/2019
3	Post-Cardiac Arrest Syndrome 09/2020 - 07/2016
3	Cardio-Renal Syndrome 08/2020 - 01/2020
3	Aneurysm (Aneurysms) 11/2018 - 01/2016
2	Immunoglobulin Light-chain Amyloidosis 06/2022 - 01/2022
2	Heart Diseases (Heart Disease) 02/2022 - 01/2013
2	Chronic Disease (Chronic Diseases) 01/2021 - 01/2018
2	Thrombosis (Thrombus) 01/2021 - 02/2015
2	Out-of-Hospital Cardiac Arrest 01/2021 - 10/2017
2	Insulin Resistance 01/2021 - 01/2019
2	Chronic Kidney Failure (Chronic Renal Failure) 11/2020 - 12/2016
2	Diabetic Nephropathies (Diabetic Nephropathy) 10/2020 - 11/2012
2	Hemorrhage 01/2020 - 01/2017
2	Pulmonary Arterial Hypertension 01/2020 - 01/2012
2	Necrosis 01/2020 - 03/2013
2	Renal Insufficiency (Renal Failure) 01/2020 - 10/2010
2	Weight Loss (Weight Reduction) 01/2019 - 01/2017
2	Hyperglycemia 06/2017 - 01/2014
2	Left Ventricular Dysfunction 01/2017 - 08/2015

Drug/Important Bio-Agent (IBA)

17	HydrogenIBA 01/2024 - 08/2008
10	CytokinesIBA 03/2023 - 02/2010
9	OsteopontinIBA 03/2023 - 10/2010
9	Glucose (Dextrose)FDA LinkGeneric 03/2023 - 10/2010
7	Sodium-Glucose Transporter 2 InhibitorsIBA 10/2020 - 12/2016
7	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2002
6	Oxygen (Dioxygen)IBA 12/2023 - 12/2016
5	LipidsIBA 10/2023 - 01/2012
5	Sodium-Glucose Transport ProteinsIBA 01/2020 - 12/2016
4	Prealbumin (Transthyretin)IBA 06/2022 - 12/2019
4	Fatty Acids (Saturated Fatty Acids)IBA 02/2022 - 01/2018
4	AntioxidantsIBA 02/2022 - 07/2009
4	RNA Polymerase II (RNA Polymerase B)IBA 01/2012 - 03/2003
3	InterleukinsIBA 03/2023 - 02/2014
3	C-Reactive ProteinIBA 03/2023 - 06/2013
3	Interleukin-6 (Interleukin 6)IBA 03/2023 - 02/2015
3	Blood Glucose (Blood Sugar)IBA 03/2023 - 01/2018
3	Therapeutic UsesIBA 06/2022 - 05/2015
3	Transcription Factors (Transcription Factor)IBA 01/2022 - 10/2004
3	SaltsIBA 01/2020 - 05/2012
3	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2019 - 01/2012
3	Sitagliptin Phosphate (Januvia)FDA Link 12/2018 - 01/2012
3	Adenosine Triphosphate (ATP)IBA 01/2018 - 06/2012
3	GlucocorticoidsIBA 01/2014 - 06/2009
3	LipocalinsIBA 01/2014 - 06/2009
3	AldehydesIBA 09/2012 - 11/2009
2	hydroxide ionIBA 04/2024 - 01/2017
2	Histones (Histone)IBA 04/2024 - 01/2017
2	Glutathione (Reduced Glutathione)IBA 10/2023 - 11/2009
2	InflammasomesIBA 03/2023 - 08/2022
2	tocilizumab (atlizumab)FDA Link 03/2023 - 05/2014
2	SodiumIBA 03/2023 - 08/2020
2	SymportersIBA 03/2023 - 08/2020
2	Amyloid (Amyloid Fibrils)IBA 06/2022 - 01/2022
2	diphosphoric acid (pyrophosphoric acid)IBA 03/2022 - 01/2022
2	Nonesterified Fatty Acids (NEFA)IBA 01/2022 - 01/2013
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2022 - 07/2014
2	AldosteroneIBA 01/2020 - 05/2012
2	CatecholaminesIBA 01/2020 - 05/2007
2	Galectins (Galectin)IBA 01/2020 - 10/2018
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019 - 12/2016
2	CarbohydratesIBA 01/2019 - 07/2009
2	empagliflozinIBA 12/2018 - 12/2016
2	Trinitrotoluene (TNT)IBA 01/2017 - 01/2014

Therapy/Procedure

21	Therapeutics 03/2023 - 08/2008
4	Caloric Restriction 01/2021 - 08/2011
4	Resuscitation 01/2020 - 12/2014
4	Glycemic Control 06/2017 - 01/2012
3	Secondary Prevention 03/2023 - 01/2021
3	Drug Therapy (Chemotherapy) 08/2022 - 01/2019
3	Transplantation 01/2020 - 01/2013
3	Percutaneous Coronary Intervention 06/2017 - 01/2015
3	Induced Hypothermia 09/2015 - 10/2012
2	Nephrectomy 01/2024 - 04/2022